{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T20:40:04Z","timestamp":1775940004328,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11883-012-0243-2","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T06:21:02Z","timestamp":1334643662000},"page":"227-234","source":"Crossref","is-referenced-by-count":34,"title":["The Complex Genetic Basis of Plasma Triglycerides"],"prefix":"10.1007","volume":"14","author":[{"given":"Christopher T.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"243_CR1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","volume":"298","author":"S Bansal","year":"2007","unstructured":"Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309\u201316.","journal-title":"JAMA"},{"key":"243_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299\u2013308.","journal-title":"JAMA"},{"key":"243_CR3","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/ATVBAHA.111.226100","volume":"31","author":"IJ Goldberg","year":"2011","unstructured":"\u2022 Goldberg IJ, Eckel RH, McPherson R. Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol. 2011;31:1716\u201325. This is a thorough recent review addressing the evidence supporting both direct and indirect relationships between plasma TG concentration and cardiovascular disease.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"243_CR4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11886-011-0220-3","volume":"13","author":"BG Talayero","year":"2011","unstructured":"Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011;13:544\u201352.","journal-title":"Curr Cardiol Rep"},{"key":"243_CR5","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Sandhu MS, Ricketts SL, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010;375:1634\u20139.","journal-title":"Lancet"},{"key":"243_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MOL.0b013e32834477d2","volume":"22","author":"BG Nordestgaard","year":"2011","unstructured":"Nordestgaard BG, Tybjaerg-Hansen A. Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk. Curr Opin Lipidol. 2011;22:113\u201322.","journal-title":"Curr Opin Lipidol"},{"key":"243_CR7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","volume":"176","author":"G Yuan","year":"2007","unstructured":"Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007;176:1113\u201320.","journal-title":"CMAJ"},{"key":"243_CR8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0021-9258(18)94212-2","volume":"264","author":"TG Kirchgessner","year":"1989","unstructured":"Kirchgessner TG, LeBoeuf RC, Langner CA, et al. Genetic and developmental regulation of the lipoprotein lipase gene: loci both distal and proximal to the lipoprotein lipase structural gene control enzyme expression. J Biol Chem. 1989;264:1473\u201382.","journal-title":"J Biol Chem"},{"key":"243_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-291X(70)90468-7","volume":"41","author":"JC LaRosa","year":"1970","unstructured":"LaRosa JC, Levy RI, Herbert P, et al. A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun. 1970;41:57\u201362.","journal-title":"Biochem Biophys Res Commun"},{"key":"243_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1373\/clinchem.2004.044826","volume":"51","author":"V Charlton-Menys","year":"2005","unstructured":"Charlton-Menys V, Durrington PN. Apolipoprotein A5 and hypertriglyceridemia. Clin Chem. 2005;51:295\u20137.","journal-title":"Clin Chem"},{"key":"243_CR11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","volume":"39","author":"M Peterfy","year":"2007","unstructured":"Peterfy M, Ben-Zeev O, Mao HZ, et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat Genet. 2007;39:1483\u20137.","journal-title":"Nat Genet"},{"key":"243_CR12","doi-asserted-by":"crossref","unstructured":"Davies BS, Beigneux AP, Fong LG, Young SG. New wrinkles in lipoprotein lipase biology. Curr Opin Lipidol. 2012;23:35\u201342.","DOI":"10.1097\/MOL.0b013e32834d0b33"},{"key":"243_CR13","unstructured":"\u2022 Johansen CT, Hegele RA. Allelic and phenotypic spectrum of plasma triglycerides. Biochim Biophys Acta 2011:In press. This is a comprehensive review first describing our model for the allelic and phenotypic spectrum of plasma TG and HTG susceptibility."},{"key":"243_CR14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","volume":"25","author":"C Priore Oliva","year":"2005","unstructured":"Priore Oliva C, Pisciotta L, Li Volti G, et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2005;25:411\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"243_CR15","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","volume":"115","author":"C Marcais","year":"2005","unstructured":"Marcais C, Verges B, Charriere S, et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest. 2005;115:2862\u20139.","journal-title":"J Clin Invest"},{"key":"243_CR16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2796.2007.01912.x","volume":"263","author":"C Priore Oliva","year":"2008","unstructured":"Priore Oliva C, Carubbi F, Schaap FG, et al. Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene. J Intern Med. 2008;263:450\u20138.","journal-title":"J Intern Med"},{"key":"243_CR17","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1210\/jc.2009-0594","volume":"94","author":"AB Cefalu","year":"2009","unstructured":"Cefalu AB, Noto D, Arpi ML, et al. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. J Clin Endocrinol Metab. 2009;94:4584\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"243_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/CIRCGENETICS.109.908905","volume":"3","author":"R Franssen","year":"2010","unstructured":"Franssen R, Young SG, Peelman F, et al. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ Cardiovasc Genet. 2010;3:169\u201378.","journal-title":"Circ Cardiovasc Genet"},{"key":"243_CR19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1194\/jlr.M002717","volume":"51","author":"G Olivecrona","year":"2010","unstructured":"Olivecrona G, Ehrenborg E, Semb H, et al. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J Lipid Res. 2010;51:1535\u201345.","journal-title":"J Lipid Res"},{"key":"243_CR20","doi-asserted-by":"crossref","unstructured":"Coca-Prieto I, Kroupa O, Gonzalez-Santos P et al. Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation. J Intern Med. 2011;270:224\u20138.","DOI":"10.1111\/j.1365-2796.2011.02361.x"},{"key":"243_CR21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/ATVBAHA.109.186577","volume":"29","author":"AP Beigneux","year":"2009","unstructured":"Beigneux AP, Franssen R, Bensadoun A, et al. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler Thromb Vasc Biol. 2009;29:956\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"243_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-511X-6-23","volume":"6","author":"J Wang","year":"2007","unstructured":"Wang J, Hegele RA. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Lipids Health Dis. 2007;6:23.","journal-title":"Lipids Health Dis"},{"key":"243_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","volume":"52","author":"CT Johansen","year":"2011","unstructured":"Johansen CT, Kathiresan S, Hegele RA. Genetic determinants of plasma triglycerides. J Lipid Res. 2011;52:189\u2013206.","journal-title":"J Lipid Res"},{"key":"243_CR24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ng.628","volume":"42","author":"CT Johansen","year":"2010","unstructured":"Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet. 2010;42:684\u20137.","journal-title":"Nat Genet"},{"key":"243_CR25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","volume":"466","author":"TM Teslovich","year":"2010","unstructured":"Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707\u201313.","journal-title":"Nature"},{"key":"243_CR26","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.111.226365","volume":"31","author":"CT Johansen","year":"2011","unstructured":"Johansen CT, Wang J, Lanktree MB, et al. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2011;31:1916\u201326.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"243_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","volume":"22","author":"CT Johansen","year":"2011","unstructured":"Johansen CT, Hegele RA. Genetic bases of hypertriglyceridemic phenotypes. Curr Opin Lipidol. 2011;22:247\u201353.","journal-title":"Curr Opin Lipidol"},{"key":"243_CR28","doi-asserted-by":"crossref","unstructured":"Johansen CT, Wang J, McIntyre AD et al. Excess of rare variants in non-GWAS candidate genes in patients with hypertriglyceridemia. Circ Cardiovasc Genet. 2012;5:66\u201372. This is a rare variant accumulation study implicating non-GWAS candidate genes in HTG susceptibility using novel analytical strategies.","DOI":"10.1161\/CIRCGENETICS.111.960864"},{"key":"243_CR29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cmet.2010.02.016","volume":"11","author":"MW Lee","year":"2010","unstructured":"Lee MW, Chanda D, Yang J, et al. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab. 2010;11:331\u20139.","journal-title":"Cell Metab"},{"key":"243_CR30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.2347","volume":"17","author":"JH Lee","year":"2011","unstructured":"Lee JH, Giannikopoulos P, Duncan SA, et al. The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nat Med. 2011;17:812\u20135.","journal-title":"Nat Med"},{"key":"243_CR31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCGENETICS.109.902320","volume":"3","author":"PS Gargalovic","year":"2010","unstructured":"Gargalovic PS, Erbilgin A, Kohannim O, et al. Quantitative trait locus mapping and identification of Zhx2 as a novel regulator of plasma lipid metabolism. Circ Cardiovasc Genet. 2010;3:60\u20137.","journal-title":"Circ Cardiovasc Genet"},{"key":"243_CR32","first-page":"11","volume":"29","author":"JR Burnett","year":"2008","unstructured":"Burnett JR, Hooper AJ. Common and rare gene variants affecting plasma LDL cholesterol. Clin Biochem Rev. 2008;29:11\u201326.","journal-title":"Clin Biochem Rev"},{"key":"243_CR33","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","volume":"363","author":"K Musunuru","year":"2010","unstructured":"Musunuru K, Pirruccello JP, Do R, et al. Exome Sequencing, Mutations in ANGPTL3, and Familial Combined Hypolipidemia. N Engl J Med. 2010;363:2220\u20137.","journal-title":"N Engl J Med"},{"key":"243_CR34","doi-asserted-by":"crossref","unstructured":"Pisciotta L, Favari E, Magnolo AL et al. Characterization of three kindreds with familial combined hypolipidemia due to loss of function mutations of ANGPTL3. Circ Cardiovasc Genet. 2012;5:42\u201350.","DOI":"10.1161\/CIRCGENETICS.111.960674"},{"key":"243_CR35","first-page":"70","volume":"119","author":"S Romeo","year":"2009","unstructured":"Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest. 2009;119:70\u20139.","journal-title":"J Clin Invest"},{"key":"243_CR36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng1984","volume":"39","author":"S Romeo","year":"2007","unstructured":"Romeo S, Pennacchio LA, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007;39:513\u20136.","journal-title":"Nat Genet"},{"key":"243_CR37","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","volume":"322","author":"TI Pollin","year":"2008","unstructured":"Pollin TI, Damcott CM, Shen H, et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science. 2008;322:1702\u20135.","journal-title":"Science"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-012-0243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-012-0243-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-012-0243-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T01:51:57Z","timestamp":1642038717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-012-0243-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1007\/s11883-012-0243-2","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}